Skip to content

Operating Income at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$69.79M-8.3%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-$108.54M-28.6%
CG Oncology logo
CG OncologyCGON
-$66.39M-57.3%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
-$19.46M-6.8%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$30.93M+27.9%
Johnson & Johnson logo
Johnson & JohnsonJNJ

Other financials

Income statement

See full
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s operating income?
Aura Biosciences, Inc. (AURA) reported operating income of -$34.87M in Q1 2026.
How has Aura Biosciences, Inc.'s operating income changed year-over-year?
Aura Biosciences, Inc.'s operating income decreased by 20.1% year-over-year, from -$29.04M to -$34.87M.
What is the long-term trend for Aura Biosciences, Inc.'s operating income?
Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s operating income has grown at a 33.7% compound annual growth rate (CAGR), from -$35.25M to -$112.79M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.